COVID-19 vaccine challenges: What have we learned so far and what remains to be done?
Open Access
- 26 March 2021
- journal article
- research article
- Published by Elsevier BV in Health Policy
- Vol. 125 (5), 553-567
- https://doi.org/10.1016/j.healthpol.2021.03.013
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review)International Journal of Molecular Medicine, 2020
- Ensuring global access to COVID-19 vaccinesThe Lancet, 2020
- Without food, there can be no exit from the pandemicNature, 2020
- Human Challenge Studies to Accelerate Coronavirus Vaccine LicensureThe Journal of Infectious Diseases, 2020
- Vaccine hesitancy and (fake) news: Quasi‐experimental evidence from ItalyHealth Economics, 2019
- Increasing Vaccination: Putting Psychological Science Into ActionPsychological Science in the Public Interest, 2017
- Systems, not pills: The options market for antibiotics seeks to rejuvenate the antibiotic pipelineSocial Science & Medicine (1982), 2016
- How to deal with vaccine hesitancy?Vaccine, 2015
- Incentives for new antibiotics: the Options Market for Antibiotics (OMA) modelGlobalization and Health, 2013
- Applying the concepts of financial options to stimulate vaccine developmentNature Reviews Drug Discovery, 2006